MLSS Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

2.31M

+14.7%

-0.015

-50%

2.35M

+5.36%

-0.020

-0%

2.60M

+11.9%

-0.010

-50%

Estimates Revision

The market is revising Upward the revenue expectations for Milestone Scientific Inc. (MLSS) for FY2025, with the revenue forecasts being adjusted by 0.9% over the past three months. During the same period, the stock price has changed by -45.62%.

Revenue Estimates for FY2025

Revise Upward

+0.9%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-45.62%

In Past 3 Month

2 Analyst Rating

Wall Street analysts forecast MLSS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MLSS is 1.00 USD with a low forecast of 1.00 USD and a high forecast of 1.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

1.00

Averages

1.00

High

1.00

Current: 0.000

Low

1.00

Averages

1.00

High

1.00

Benchmark

Speculative Buy

downgrade

2025-11-20

Reason

Benchmark

Price Target

2025-11-20

downgrade

Speculative Buy

Reason

Benchmark lowered the firm's price target on Milestone Scientific to $1 from $1.25 and keeps a Speculative Buy rating on the shares. Sales traction for the Medical business has proven to be elusive, so the firm is lowering its forward revenue estimates, noting that its 2030 revenue estimate of $22M is discounted to the end of 2026 at 8.2% to arrive at its lowered price target.

Valuation Metrics

The current forward P/E ratio for Milestone Scientific Inc (MLSS.A) is -5.36, compared to its 5-year average forward P/E of -15.71. For a more detailed relative valuation and DCF analysis to assess Milestone Scientific Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-15.71

Current PE

-5.36

Overvalued PE

-8.28

Undervalued PE

-23.15

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

7.91

Current PS

2.37

Overvalued PS

12.76

Undervalued PS

3.05

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders areSelling! The selling amount has increased 2723.48% over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders areSelling! The selling amount has increased 2723.48% over the last month.

Sold

Bought

MLSS News & Events

Events Timeline

No data

News

5.0

2025-12-31Benzinga

Vanda Pharmaceuticals' NEREUS Receives FDA Approval, Shares Surge 17.5%

4.0

2025-11-20Benzinga

Benchmark Keeps Speculative Buy Rating on Milestone Scientific, Reduces Price Target to $1

2.0

2025-11-14Benzinga

RLX Technology Shares Rise 6%; Check Out 20 Stocks Making Moves in Premarket Trading

People Also Watch

Frequently Asked Questions

What is Milestone Scientific Inc (MLSS) stock price today?

The current price of MLSS is 0.292 USD — it has increased 1.74 % in the last trading day.

What is Milestone Scientific Inc (MLSS)'s business?

Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.

What is the price predicton of MLSS Stock?

What is Milestone Scientific Inc (MLSS)'s revenue for the last quarter?

Milestone Scientific Inc revenue for the last quarter amounts to 2.36M USD, decreased -6.11 % YoY.

What is Milestone Scientific Inc (MLSS)'s earnings per share (EPS) for the last quarter?

Milestone Scientific Inc. EPS for the last quarter amounts to -0.01 USD, decreased -50.00 % YoY.

What changes have occurred in the market's expectations for Milestone Scientific Inc (MLSS)'s fundamentals?

How many employees does Milestone Scientific Inc (MLSS). have?

Milestone Scientific Inc (MLSS) has 17 emplpoyees as of January 09 2026.

What is Milestone Scientific Inc (MLSS) market cap?

Today MLSS has the market capitalization of 22.96M USD.